Sionna Therapeutics Statistics
Total Valuation
SION has a market cap or net worth of $1.56 billion. The enterprise value is $1.26 billion.
Important Dates
The last earnings date was Monday, March 2, 2026, before market open.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SION has 45.00 million shares outstanding. The number of shares has increased by 935.60% in one year.
| Current Share Class | 45.00M |
| Shares Outstanding | 45.00M |
| Shares Change (YoY) | +935.60% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 39.38% |
| Float | 15.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.97 |
| P/TBV Ratio | 5.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.61, with a Debt / Equity ratio of 0.03.
| Current Ratio | 20.61 |
| Quick Ratio | 20.14 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.79% and return on invested capital (ROIC) is -22.61%.
| Return on Equity (ROE) | -31.79% |
| Return on Assets (ROA) | -21.74% |
| Return on Invested Capital (ROIC) | -22.61% |
| Return on Capital Employed (ROCE) | -28.32% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.57M |
| Employee Count | 48 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +145.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +145.21% |
| 50-Day Moving Average | 39.46 |
| 200-Day Moving Average | 29.50 |
| Relative Strength Index (RSI) | 42.41 |
| Average Volume (20 Days) | 244,861 |
Short Selling Information
The latest short interest is 3.06 million, so 6.81% of the outstanding shares have been sold short.
| Short Interest | 3.06M |
| Short Previous Month | 3.14M |
| Short % of Shares Out | 6.81% |
| Short % of Float | 19.76% |
| Short Ratio (days to cover) | 9.72 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -88.98M |
| Pretax Income | -75.27M |
| Net Income | -75.27M |
| EBITDA | -88.34M |
| EBIT | -88.98M |
| Earnings Per Share (EPS) | -$1.88 |
Full Income Statement Balance Sheet
The company has $235.88 million in cash and $8.68 million in debt, with a net cash position of $301.63 million or $6.70 per share.
| Cash & Cash Equivalents | 235.88M |
| Total Debt | 8.68M |
| Net Cash | 301.63M |
| Net Cash Per Share | $6.70 |
| Equity (Book Value) | 306.83M |
| Book Value Per Share | 6.86 |
| Working Capital | 229.71M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$66.30 million and capital expenditures -$377,000, giving a free cash flow of -$66.67 million.
| Operating Cash Flow | -66.30M |
| Capital Expenditures | -377,000 |
| Free Cash Flow | -66.67M |
| FCF Per Share | -$1.48 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SION does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -935.60% |
| Shareholder Yield | -935.60% |
| Earnings Yield | -4.82% |
| FCF Yield | -4.27% |
Analyst Forecast
The average price target for SION is $46.22, which is 33.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $46.22 |
| Price Target Difference | 33.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 11.59% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |